PL2893936T3 - Glutarylohistamina do leczenia i profilaktyki chorób spowodowanych wirusami zawierającymi (+) rna - Google Patents

Glutarylohistamina do leczenia i profilaktyki chorób spowodowanych wirusami zawierającymi (+) rna

Info

Publication number
PL2893936T3
PL2893936T3 PL13833080T PL13833080T PL2893936T3 PL 2893936 T3 PL2893936 T3 PL 2893936T3 PL 13833080 T PL13833080 T PL 13833080T PL 13833080 T PL13833080 T PL 13833080T PL 2893936 T3 PL2893936 T3 PL 2893936T3
Authority
PL
Poland
Prior art keywords
prophylaxis
rna
treatment
diseases caused
containing viruses
Prior art date
Application number
PL13833080T
Other languages
English (en)
Inventor
Vladimir Evgenievich Nebolsin
Sergei Vladimirovich BORISEVICH
Andrei Yurievich EGOROV
Original Assignee
Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises" filed Critical Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises"
Publication of PL2893936T3 publication Critical patent/PL2893936T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13833080T 2012-08-30 2013-08-29 Glutarylohistamina do leczenia i profilaktyki chorób spowodowanych wirusami zawierającymi (+) rna PL2893936T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012137097/15A RU2518314C2 (ru) 2012-08-30 2012-08-30 Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами
PCT/RU2013/000751 WO2014035297A1 (ru) 2012-08-30 2013-08-29 Способ и средство для лечения и профилактики заболеваний, вызываемых (+) рнк-содержащими вирусами
EP13833080.8A EP2893936B1 (en) 2012-08-30 2013-08-29 Glutaryl histamine for the treatment and prophylaxis of diseases caused by (+)rna-containing viruses

Publications (1)

Publication Number Publication Date
PL2893936T3 true PL2893936T3 (pl) 2018-09-28

Family

ID=50183972

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13833080T PL2893936T3 (pl) 2012-08-30 2013-08-29 Glutarylohistamina do leczenia i profilaktyki chorób spowodowanych wirusami zawierającymi (+) rna

Country Status (17)

Country Link
US (1) US9820970B2 (pl)
EP (1) EP2893936B1 (pl)
JP (1) JP6328638B2 (pl)
CN (1) CN104684569B (pl)
CA (1) CA2883908C (pl)
CY (1) CY1120158T1 (pl)
DK (1) DK2893936T3 (pl)
EA (1) EA028541B1 (pl)
ES (1) ES2667342T3 (pl)
HK (1) HK1210025A1 (pl)
HU (1) HUE036805T2 (pl)
LT (1) LT2893936T (pl)
PL (1) PL2893936T3 (pl)
PT (1) PT2893936T (pl)
RU (1) RU2518314C2 (pl)
SI (1) SI2893936T1 (pl)
WO (1) WO2014035297A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504673B2 (en) * 2009-05-21 2016-11-29 LTD “Valenta-Intellekt” Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
RU2628800C2 (ru) * 2014-03-12 2017-08-22 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
RU2746692C1 (ru) * 2020-04-14 2021-04-19 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний
RU2770518C2 (ru) * 2020-02-11 2022-04-18 Общество С Ограниченной Ответственностью "Валента-Интеллект" Жидкая лекарственная форма для лечения и профилактики гриппа и орви
RU2744854C1 (ru) * 2020-02-11 2021-03-16 Общество С Ограниченной Ответственностью "Валента-Интеллект" Жидкая лекарственная форма для лечения и профилактики гриппа и орви
RU2770521C2 (ru) * 2020-02-11 2022-04-18 Общество С Ограниченной Ответственностью "Валента-Интеллект" Жидкая лекарственная форма для лечения и профилактики гриппа и орви
CN114984030A (zh) * 2022-06-23 2022-09-02 中国人民解放军海军军医大学 利巴韦林在制备抗蜱传脑炎病毒药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
EP1023901A4 (en) * 1997-10-13 2004-10-27 Otsuka Pharma Co Ltd MEDICINES FOR HEPATITIS C AND THE USE THEREOF
HUP0400624A2 (hu) * 1998-04-30 2004-06-28 Agouron Pharmaceuticals, Inc. Picornavírus-ellenes vegyületek, előállításuk és alkalmazásuk
RU2191594C1 (ru) * 2001-04-03 2002-10-27 Григорян Седа Суреновна Средство и способ повышения резистентности к инфекции
TWI274585B (en) * 2002-06-03 2007-03-01 Nat Health Research Institutes Pharmaceutical composition, kit, and packaged product for treating infection by a flaviviridae virus
US7605138B2 (en) * 2002-07-03 2009-10-20 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
RU2335495C2 (ru) * 2005-06-15 2008-10-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" N-ацильные производные аминокислот, их фармацевтически приемлевые соли, фармацевтическая композиция и применение в качестве гиполипидемических средств
RU2338552C2 (ru) * 2006-09-19 2008-11-20 Владимир Евгеньевич Небольсин Фармацевтическая композиция для ингаляции
US9504673B2 (en) * 2009-05-21 2016-11-29 LTD “Valenta-Intellekt” Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
RU2496512C1 (ru) * 2012-03-14 2013-10-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Способ лечения вирусного гепатита с

Also Published As

Publication number Publication date
SI2893936T1 (en) 2018-07-31
HUE036805T2 (hu) 2018-07-30
JP6328638B2 (ja) 2018-05-23
RU2518314C2 (ru) 2014-06-10
LT2893936T (lt) 2018-06-25
EA028541B1 (ru) 2017-11-30
CN104684569A (zh) 2015-06-03
US20150209330A1 (en) 2015-07-30
EA201590460A1 (ru) 2015-06-30
CN104684569B (zh) 2018-03-02
CA2883908C (en) 2019-06-04
CA2883908A1 (en) 2014-03-06
DK2893936T3 (en) 2018-05-28
EP2893936B1 (en) 2018-04-04
EP2893936A1 (en) 2015-07-15
HK1210025A1 (en) 2016-04-15
EP2893936A4 (en) 2016-03-16
WO2014035297A1 (ru) 2014-03-06
ES2667342T3 (es) 2018-05-10
JP2015526513A (ja) 2015-09-10
CY1120158T1 (el) 2018-12-12
RU2012137097A (ru) 2014-03-10
PT2893936T (pt) 2018-05-02
US9820970B2 (en) 2017-11-21

Similar Documents

Publication Publication Date Title
HK1252786A1 (zh) 包含5-苯氧基-3h-嘧啶-4-酮衍生物的組合物及其用於預防或治療hiv感染的方法
HK1207636A1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
HK1210152A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 6-
HK1210463A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1210022A1 (en) Methods for the treatment of hepatitis b and hepatitis d infections
PT2893936T (pt) Glutaril-histamina para o tratamento e profilaxia de doenças provocadas por vírus que contêm arn(+)
HK1208680A1 (en) Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
HK1201181A1 (en) Novel cyclosporin derivatives for the treatment and prevention of viral infections
ZA201306342B (en) The treatment of viral infections
HK1206594A1 (en) Materials and methods for prevention and treatment of viral infections